Medical Services International Inc. Contracts to Sell Over 1.0 Million Rapid Test Kits Business Wire
click here to return to Business Wire main menu
DonateNow





Medical Services International Inc. Contracts to Sell Over 1.0 Million Rapid Test Kits

Business Wire - June 12, 2002


EDMONTON, Alberta--(BW HealthWire)--June 12, 2002--Medical Services International Inc. (Pink Sheets:MSITF) is pleased to announce that it now has contracts to supply over 1,300,000 VScan(TM) Rapid Test Kits in the next year.

It is projected that these contracts will generate a minimum of $3,120,000 U.S.D. in revenue to Medical Services International Inc. Based on requests for samples related to independent testing, the Company anticipates that additional contracts will be signed to supply another 1,500,000 test kits in the next year. The existing contracts relate to the HIV Test Kits only. Additional testing is being done on the Tuberculosis (TB) Test Kits. Initial results are excellent, and there is substantial interest in these kits. The Company projects that it will supply in excess of 800,000 TB Test Kits in the next year.

Robert Talbot states: "The marketing of the VScan(TM) Rapid Test Kits has only just gotten started. Our historical test results, combined with the test results being obtained from sending samples for testing to different countries, should result in the negotiation of several additional large contracts to supply the test kits. Our distributors are now fully active in the marketing of the test kits."

About Medical Services International Inc.

Medical Services International Inc. is a medically related holding company comprised of two core businesses. The company operates medical facilities on Anguilla, B.W.I., that supply medical diagnostic services and dialysis. The facility combines the recreational aspects of a Caribbean destination with the availability of North American quality medical services. The diagnostic test division was created in response to a worldwide demand for less costly, rapid technically simplified test methods to test for infectious diseases. The company has developed its VScan(TM) Rapid Test Kits for the detection of HIV 1 & 2, Hepatitis B and C and Tuberculosis. The company is currently in negotiations with major healthcare concerns to supply these tests to the worldwide market.

Medical Services International Inc. has also acquired a strategic interest in a call center operator (Teltek International Limited) based in the British West Indies. The call center operation operates full-service call centers with the latest customer relationship management technology specializing in providing call center out-sourcing solutions and out-bound telemarketing services to major U.S. multi-national corporations.

Medical Services International Inc. trades in the United States on the NQB Pink Sheets under the symbol "MSITF."

For further information, please contact Robert Talbot at 780/430-6363; Corporate Website: www.MedicalServicesIntl.com.

Note: Certain statements in this news release are "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Such statements involve known and unknown risks, uncertainties and other factors that may cause results to differ materially. Such risks, uncertainties and other factors include, but are not limited to, new economic conditions, risk in product technology developments, market acceptance of new product and continuing product demand, level of competition and other factors described in the company reports, prospectus and other filings with the Securities and Exchange Commission.

CONTACT: Medical Services International Inc., Edmonton Robert Talbot, 780/430-6363

SOURCE: Medical Services International Inc.


020612
BW020608


Copyright © 2002 - Business Wire. All rights reserved. Reproduced with permission. Reproduction of this article (other than one copy for personal reference) must be cleared through the Business Wire, Permissions Desk, Business Wire, 1185 Avenue of the Americas, 3rd Floor, New York, NY 10036; Tel: (212) 575-8822; FAX: (212) 575-1854. http://www.businesswire.com.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Broadway Cares/Equity Fights AIDS, Elton John AIDS Foundation, the National Library of Medicine, Pacific Life Foundation and donations from users like you.

Always watch for outdated information. This article first appeared in 2002. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 2002. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .